News

Berlin: Bayer has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA, regulatory authority ...
Plenty of people working outside the office say they sometimes take a short snooze on the job, and managers lead the pack in ...
Onco360®, the nation’s leading independent specialty pharmacy, has added Augtyro™ (repotrectinib) manufactured by Bristol ...
Elinzanetant is the first neurokinin-targeted therapy to demonstrate efficacy in reducing vasomotor symptoms (VMS)” — otherwise known as hot flashes — “in women with breast cancer,” Fatima Cardoso, MD ...
Johnson & Johnson submits sNDA to US FDA for Caplyta for prevention of relapse in schizophrenia: Titusville, New Jersey Wednesday, July 9, 2025, 14:00 Hrs [IST] Johnson & Johnson ...
South Shore Health's Dr. Todd Ellerin says a study recently showed that there was a 45% increase in obstructive sleep apnea ...
Patients with migraine discontinued treatment less often with atogepant and experienced a greater reduction in mean monthly ...
When Ben Stokes insisted on the eve of the third Test that England were not 'stuck in our ways', he was talking about the ...
Irish News editorial lauding the scale of the work completed by the Boundary Commissioners who interviewed over 575 witnesses ...
Experts explain why women may need more rest than men Biological factors such as hormonal fluctuations, can make sleep disturbances more common and increase the risk of developing sleep disorders ...
The Food Standards Authority (FSA) has advised CBD businesses to reformulate their products "to improve consumer safety".